SentiSense
Ctrl+K
Quick tip: Press
to search stocks
B
BMY
Bristol Myers Squibb Company
$59.08
+0.13 (+0.22%)
Summary
Stories
News
Metrics
Fundamentals
Holders
Full institutional holders data is a Pro feature
UpgradeInstitutional Holders
2226
tracked filers
Total Institutional Value
$34.7B
2226 holders tracked
Report Date
Q4 2025
SEC 13F-HR filing
Notable changes (2)
| Holder | Category | Shares | Value | Weight | Change |
|---|---|---|---|---|---|
STATE STREET CORP | Index Fund | 96.6M | $4.4B | -- | +2.0% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Pension | 73.0M | $3.3B | -- | +20.5% |
GEODE CAPITAL MANAGEMENT, LLC | Index Fund | 40.8M | $1.8B | -- | +0.4% |
NORGES BANK | Sovereign Wealth | 34.4M | $1.8B | -- | +2.4% |
Capital International Investors | Other | 32.4M | $1.5B | -- | -51.0% |
Data source: SEC EDGAR 13F-HR filings
Company Profile
Symbol
BMY
Market Cap
$120.05B
IPO Date
Jun 23, 1952
CEO
Chris Boerner
Employees
32,500
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Read MoreSimilar Stocks
ABBV
AbbVie Inc.
$219.68
-2.52%
MRK
Merck & Co., Inc.
$115.61
-0.26%